HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liping Liu Selected Research

Disease Progression

1/2023Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial.
1/2022Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
6/2018Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance.
1/2018Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
1/2017Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liping Liu Research Topics

Disease

163Stroke (Strokes)
04/2024 - 05/2006
135Ischemic Stroke
06/2024 - 05/2008
90Neoplasms (Cancer)
03/2024 - 11/2003
55Transient Ischemic Attack
02/2024 - 05/2008
33Hemorrhage
02/2024 - 05/2010
29Inflammation (Inflammations)
03/2023 - 01/2005
23Breast Neoplasms (Breast Cancer)
01/2024 - 05/2008
18Infections
01/2023 - 08/2009
18Diabetes Mellitus
01/2022 - 05/2008
17Hepatocellular Carcinoma (Hepatoma)
02/2024 - 05/2014
16Neoplasm Metastasis (Metastasis)
01/2024 - 06/2004
16Pathologic Constriction (Stenosis)
11/2023 - 01/2012
15Cerebral Hemorrhage
12/2023 - 05/2008
13Hypoxia (Hypoxemia)
02/2024 - 06/2004
13Atherosclerosis
12/2023 - 03/2006
13Hypertension (High Blood Pressure)
01/2022 - 05/2009
12Infarction (Infarctions)
06/2024 - 05/2006
12Atrial Fibrillation
12/2023 - 05/2014
9Lung Neoplasms (Lung Cancer)
11/2023 - 03/2016
8Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 12/2004
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 10/2004
7Colitis
11/2022 - 03/2012
7Glioma (Gliomas)
01/2022 - 05/2010
7Hyperglycemia
01/2021 - 01/2017
6COVID-19
03/2024 - 10/2021
6Brain Ischemia (Cerebral Ischemia)
01/2024 - 01/2007
6Fibrosis (Cirrhosis)
01/2024 - 01/2008
6Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2023 - 06/2013
6Asthma (Bronchial Asthma)
12/2023 - 03/2015
6Thrombosis (Thrombus)
07/2023 - 01/2016
6Hematoma
01/2023 - 05/2010
6Insulin Resistance
03/2022 - 01/2017
6Carcinogenesis
01/2022 - 07/2013
6Multiple Myeloma
01/2020 - 06/2012
6Hypothermia
05/2019 - 01/2007
5Coronary Disease (Coronary Heart Disease)
02/2024 - 10/2011
5Myocardial Infarction
02/2024 - 08/2009
5Disease Progression
01/2023 - 01/2017
5Sepsis (Septicemia)
01/2023 - 06/2019
5Stomach Neoplasms (Stomach Cancer)
11/2022 - 10/2018
5Chronic Renal Insufficiency
01/2022 - 01/2014
5Melanoma (Melanoma, Malignant)
06/2021 - 07/2017
5Neuroinflammatory Diseases
11/2020 - 01/2007
5Carcinoma (Carcinomatosis)
09/2019 - 10/2009
5Burns
05/2016 - 05/2014
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2024 - 01/2020
4Reperfusion Injury
01/2024 - 02/2019
4Brain Neoplasms (Brain Tumor)
11/2023 - 01/2020

Drug/Important Bio-Agent (IBA)

58Clopidogrel (Plavix)FDA Link
02/2024 - 07/2013
48Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2024 - 07/2013
36Proteins (Proteins, Gene)FDA Link
01/2024 - 06/2004
32Glucose (Dextrose)FDA LinkGeneric
03/2022 - 06/2004
27Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2013
23Cytochrome P-450 CYP2C19IBA
02/2024 - 07/2016
21TicagrelorIBA
02/2024 - 01/2017
14Antihypertensive Agents (Antihypertensives)IBA
02/2024 - 05/2008
13C-Reactive ProteinIBA
09/2023 - 01/2013
12Tissue Plasminogen Activator (Alteplase)FDA Link
12/2023 - 02/2009
12Indicators and Reagents (Reagents)IBA
01/2023 - 02/2012
11ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2013
10MicroRNAs (MicroRNA)IBA
05/2023 - 11/2010
9Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2012
8CytokinesIBA
01/2023 - 09/2011
8Oxygen (Dioxygen)IBA
04/2022 - 06/2005
8Messenger RNA (mRNA)IBA
10/2021 - 06/2004
7Therapeutic UsesIBA
01/2024 - 02/2019
7oxidized low density lipoproteinIBA
01/2023 - 06/2011
7BerberineIBA
01/2021 - 01/2012
7LipidsIBA
01/2020 - 10/2012
6HomocysteineIBA
02/2024 - 07/2010
6Peptides (Polypeptides)IBA
02/2024 - 06/2014
6NF-kappa B (NF-kB)IBA
01/2024 - 08/2009
6Hemoglobins (Hemoglobin)IBA
01/2024 - 01/2016
6AlbuminsIBA
06/2023 - 03/2015
6danaparoid (Orgaran)FDA Link
01/2023 - 07/2010
6pyrotinibIBA
01/2023 - 01/2020
6Circulating Tumor DNAIBA
09/2022 - 01/2018
6Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2007
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2018
6Matrix Metalloproteinases (MMPs)IBA
09/2019 - 07/2008
5VaccinesIBA
04/2024 - 06/2016
5AntigensIBA
02/2024 - 12/2017
5Transcription Factors (Transcription Factor)IBA
02/2024 - 05/2008
5AllergensIBA
12/2023 - 03/2015
5Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2023 - 05/2010
5CateninsIBA
01/2023 - 01/2018
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023 - 01/2014
5EnzymesIBA
10/2022 - 01/2019
5Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2019
5LDL CholesterolIBA
01/2022 - 06/2013
5RNA (Ribonucleic Acid)IBA
01/2022 - 09/2012
4CholesterolIBA
01/2024 - 11/2020
4Interleukin-17 (Interleukin 17)IBA
12/2023 - 03/2010
4Uric Acid (Urate)IBA
12/2023 - 03/2014

Therapy/Procedure

138Therapeutics
06/2024 - 06/2004
18Drug Therapy (Chemotherapy)
01/2023 - 10/2004
17Secondary Prevention
02/2024 - 05/2008
14Thrombectomy
05/2024 - 06/2016
6Length of Stay
01/2023 - 12/2011
5Radiotherapy
01/2022 - 09/2019